Graeme E. Walker

2.4k citations

23 papers · 1.2k indexed · h-index 16

Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment 3
Acoustics and Ultrasonics
Oncology top 10%
Molecular Biology
- DNA Repair Mechanisms 3
- Cancer therapeutics and mechanisms 3
- Protein Degradation and Inhibitors 2
Obstetrics and Gynecology top 10%
- Endometrial and Cervical Cancer Treatments 2
Genetics
- Estrogen and related hormone effects 7
Pulmonary and Respiratory Medicine
- Prostate Cancer Treatment and Research 3
Radiology, Nuclear Medicine and Imaging
- Radiopharmaceutical Chemistry and Applications 2

Co-authors: Sonja Franke‐Arnold Aidan S. Arnold Simon P. Langdon Alistair Williams John F. Smyth David Cameron Karen J. Taylor Elizabeth Mouchet
Cited by: Reproductive Medicine Acoustics and Ultrasonics Oncology
Journals: Molecular Cancer Therapeutics (3 papers)Clinical Cancer Research (2 papers)Microbiology (2 papers)
Partner nations: United Kingdom United States Switzerland

In The Last Decade

Graeme E. Walker

22 papers receiving 1.2k citations

Peers

Countries citing papers authored by Graeme E. Walker

Since Specialization

Citations

This map shows the geographic impact of Graeme E. Walker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Graeme E. Walker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Graeme E. Walker more than expected).

Fields of papers citing papers by Graeme E. Walker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Graeme E. Walker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Graeme E. Walker. The network helps show where Graeme E. Walker may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Graeme E. Walker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Graeme E. Walker Line = papers co-authored together Graeme E. Walker links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Psychological defence mechanisms during the COVID-19 pandemic: A case series The European Journal of Psychiatry ·Graeme E. Walker,Franz Eibner	2020	24
2	Potent and Selective Inhibitors of MTH1 Probe Its Role in Cancer Cell Survival Journal of Medicinal Chemistry ·Jason G. Kettle,Abhijeet Satwekar,Michał Biśta,J. Breed,Nichola L. Davies,이해진,Shaun Fillery,Kevin M. Foote,Louise Goodwin,David R. Jones,Helena Käck,Alan Lau,J. Willem M. Nissink,Jon Read,James S. Scott,Ben Taylor,Graeme E. Walker,Lisa Wissler,Marta Wylot	2016	100
3	Overcoming Obstacles in the Implementation of Factorial Design for Assay Optimization Assay and Drug Development Technologies ·Justine Szumielewski,Martina Fitzek,Elizabeth Mouchet,Graeme E. Walker,Philip Jarvis	2015	4
4	A Screening Assay Cascade to Identify and Characterize Novel Selective Estrogen Receptor Downregulators (SERDs) SLAS DISCOVERY ·Rowena Callis,Alfred A. Rabow,Michael Tonge,Robert H. Bradbury,Mairi Challinor,Karen Roberts,Karen L. Jones,Graeme E. Walker	2015	22
5	Implementation and Challenges of Direct Acoustic Dosing into Cell-Based Assays SLAS TECHNOLOGY ·Karen Roberts,Rowena Callis,R.J.C. Admiraal,15163,مهدی انوری,Eric Tang,Κωσταντίνος Σωτηρόπουλος,Graeme E. Walker	2015	15
6	Abstract 3650: Discovery of the clinical candidate AZD9496: a potent and orally bioavailable selective estrogen receptor downregulator and antagonist Cancer Research ·Chris De Savi,Robert H. Bradbury,Alfred A. Rabow,Richard A. Norman,David Buttar,Gordon S. Currie,Hazel M. Weir,Craig S. Donald,David W. Andrews,Gerardo Luiz Garcia Leitão,Peter Ballard,Jon Curwen,Zena Wilson,Graham H.P. Richmond,Celina M. D’Cruz,Steve Powell,Graeme E. Walker,Michael Hulse,Michael Tonge	2015	4
7	Cold-atom densities of more than 1012cm−3in a holographically shaped dark spontaneous-force optical trap Physical Review A ·Neal Radwell,Graeme E. Walker,Sonja Franke‐Arnold	2013	19
8	Trans-Spectral Orbital Angular Momentum Transfer via Four-Wave Mixing in Rb Vapor Physical Review Letters ·Graeme E. Walker,Aidan S. Arnold,Sonja Franke‐Arnold	2012	182
9	Abstract 3848: Preclinical profile of AZD3514: A small molecule-targeting androgen receptor function with a novel mechanism of action and the potential to treat castration-resistant prostate cancer Cancer Research ·Sarah A. Loddick,Mate Nemes,H. Boettger,Alessia Landella,Luke Gaughan,Jim Growcott,Natalie Stratton,Elizabeth Mouchet,Daniel O’Neill,Franz Schatzlmayr,David M. Robinson,Craig Robson,Sarah J. Ross,K.V.J. Koshalee,Dawn Trueman,Graeme E. Walker,Stephen R. Wedge,Nigel Brooks	2012	4
10	Small-molecule androgen receptor downregulators as an approach to treatment of advanced prostate cancer Bioorganic & Medicinal Chemistry Letters ·Robert H. Bradbury,Neil J. Hales,Alfred A. Rabow,Graeme E. Walker,David Acton,David Andrews,Peter Ballard,Nigel Brooks,Nicola Colclough,Miriam J. García-Collins,Urs J. Hancox,Owen D. Jones,David A. Jude,Sarah A. Loddick,Andrew Mortlock	2011	36
11	Discovery of novel imidazo[1,2-a]pyridines as inhibitors of the insulin-like growth factor-1 receptor tyrosine kinase Bioorganic & Medicinal Chemistry Letters ·Richard Ducray,Iain Simpson,Frédéric Jung,J. Willem M. Nissink,Peter W. Kenny,Martina Fitzek,Graeme E. Walker,Lara Ward,Kevin Hudson	2011	44
12	Abstract B107: Characterization of a small molecule selective androgen receptor downregulator: A novel approach for the treatment of castration-resistant prostate cancer. Molecular Cancer Therapeutics ·Sarah A. Loddick,Sandra R. Brave,Alessia Landella,Luke Gaughan,Jim Growcott,Ibrahim Mahmoud El-mehasseb,Elizabeth Mouchet,Daniel O’Neill,Craig Robson,K.V.J. Koshalee,Andrew Thomason,Dawn Trueman,Graeme E. Walker,Nigel Brooks	2011	0
13	Dynamic changes in gene expression in vivo predict prognosis of tamoxifen-treated patients with breast cancer Breast Cancer Research ·Karen J. Taylor,Andrew H. Sims,Liang Liang,Dana Faratian,Morwenna Muir,Graeme E. Walker,Dan Zhang,J. Michael Dixon,David Cameron,David J. Harrison,Simon P. Langdon	2010	35
14	AZD7762, a novel checkpoint kinase inhibitor, drives checkpoint abrogation and potentiates DNA-targeted therapies Molecular Cancer Therapeutics ·Sonya Zabludoff,Chun Deng,Michael Grondine,Verdouw BC,Susan Ashwell,Benjamin Caleb,Stephen Green,Robin E. Keeney,Candice L. Horn,James W. Janetka,Dongfang Liu,Elizabeth Mouchet,Shannon Ready,E. Vanramshorst,Christophe Quéva,Gary K. Schwartz,Karen J. Taylor,Archie Tse,Graeme E. Walker,汪效倚	2008	333
15	Preclinical identification of AZD7762, a novel, potent and selective inhibitor of Checkpoint kinases Molecular Cancer Therapeutics ·Susan Ashwell,Benjamin Caleb,Chun Deng,Stephen Green,Michael Grondine,Robin E. Keeney,Candice L. Horn,James W. Janetka,Dongfang Liu,Elizabeth Mouchet,Shannon Ready,E. Vanramshorst,Christophe Quéva,Karen J. Taylor,Verdouw BC,Graeme E. Walker,汪效倚,Sonya Zabludoff	2007	3
16	Estrogen-regulated gene expression predicts response to endocrine therapy in patients with ovarian cancer Gynecologic Oncology ·Graeme E. Walker,Kenneth G. MacLeod,Alistair Williams,David Cameron,John F. Smyth,Simon P. Langdon	2007	65
17	Insulin-like Growth Factor Binding Proteins IGFBP3, IGFBP4, and IGFBP5 Predict Endocrine Responsiveness in Patients with Ovarian Cancer Clinical Cancer Research ·Graeme E. Walker,Kenneth Macleod,Alistair Williams,David Cameron,John F. Smyth,Simon P. Langdon	2007	55
18	Antiestrogen Therapy Is Active in Selected Ovarian Cancer Cases: The Use of Letrozole in Estrogen Receptor–Positive Patients Clinical Cancer Research ·John F. Smyth,Charlie Gourley,Graeme E. Walker,Melanie Mackean,Ashley Skrljac,Alistair Williams,Lucy Cheng,Tzyvia Rye,Ron Rye,Moira Stewart,Baixiang Huang,Max S. Mano,Nick Reed,E. C. S.,P. Vasey,Hani Gabra,Simon P. Langdon	2007	144
19	Evidence for a novel class of microbial 3-deoxy-D-arabino-heptulosonate-7-phosphate synthase in Streptomyces coelicolor A3(2), Streptomyces rimosus and Neurospora crassa Microbiology ·Graeme E. Walker,B. Dunbar,Osama Ashfaque,Hugh G. Nimmo,J.R. Coggins	1996	57
20	The amino acid sequence of the small monomeric phosphoglycerate mutase from the fission yeast Schizosaccharomyces pombe Biochemical Journal ·Jacqueline Nairn,Nicholas C. Price,Linda A. Fothergill‐Gilmore,Graeme E. Walker,John E. Fothergill,B. Dunbar	1994	18

About Graeme E. Walker

Graeme E. Walker is a scholar working on Reproductive Medicine, Genetics, Obstetrics and Gynecology, Biotechnology and Virology, having authored 23 papers that have together received 1.2k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (7 papers), DNA Repair Mechanisms (3 papers), Ovarian cancer diagnosis and treatment (3 papers), Cancer therapeutics and mechanisms (3 papers), Prostate Cancer Treatment and Research (3 papers), Radiopharmaceutical Chemistry and Applications (2 papers), Endometrial and Cervical Cancer Treatments (2 papers) and Protein Degradation and Inhibitors (2 papers). The work is most often cited by research in Reproductive Medicine (170 citations), Acoustics and Ultrasonics (12 citations), Oncology (338 citations), Molecular Biology (610 citations) and Obstetrics and Gynecology (65 citations). Graeme E. Walker has collaborated with scholars based in United Kingdom, United States and Switzerland. Frequent co-authors include Sonja Franke‐Arnold, Aidan S. Arnold, Simon P. Langdon, Alistair Williams, John F. Smyth, David Cameron, Karen J. Taylor, Elizabeth Mouchet, Candice L. Horn and Sonya Zabludoff. Their work appears in journals such as Molecular Cancer Therapeutics, Clinical Cancer Research, Microbiology, Bioorganic & Medicinal Chemistry Letters and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact